167 related articles for article (PubMed ID: 33846766)
1. Lentivirus vector‑mediated genetic manipulation of oncogenic pathways induces tumor formation in rabbit brain.
Ahmad F; Hyvärinen A; Pirinen A; Olsson V; Rummukainen J; Immonen A; Närväinen J; Tuunanen P; Liimatainen T; Kärkkäinen V; Koistinaho J; Ylä-Ηerttuala S
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846766
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral-Induced Spinal Cord Gliomas in Rat Model.
Nagarajan PP; Tora MS; Neill SG; Federici T; Texakalidis P; Donsante A; Canoll P; Lei K; Boulis NM
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884748
[TBL] [Abstract][Full Text] [Related]
3. Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.
Metz MZ; Gutova M; Lacey SF; Abramyants Y; Vo T; Gilchrist M; Tirughana R; Ghoda LY; Barish ME; Brown CE; Najbauer J; Potter PM; Portnow J; Synold TW; Aboody KS
Stem Cells Transl Med; 2013 Dec; 2(12):983-92. PubMed ID: 24167321
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel mouse glioma model using lentiviral vectors.
Marumoto T; Tashiro A; Friedmann-Morvinski D; Scadeng M; Soda Y; Gage FH; Verma IM
Nat Med; 2009 Jan; 15(1):110-6. PubMed ID: 19122659
[TBL] [Abstract][Full Text] [Related]
5. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.
Friedmann-Morvinski D; Bushong EA; Ke E; Soda Y; Marumoto T; Singer O; Ellisman MH; Verma IM
Science; 2012 Nov; 338(6110):1080-4. PubMed ID: 23087000
[TBL] [Abstract][Full Text] [Related]
6. A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma.
Rahme GJ; Luikart BW; Cheng C; Israel MA
Neuro Oncol; 2018 Feb; 20(3):332-342. PubMed ID: 29016807
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral Vector Induced Modeling of High-Grade Spinal Cord Glioma in Minipigs.
Tora MS; Texakalidis P; Neill S; Wetzel J; Rindler RS; Hardcastle N; Nagarajan PP; Krasnopeyev A; Roach C; James R; Bruce JN; Canoll P; Federici T; Oshinski JN; Boulis NM
Sci Rep; 2020 Mar; 10(1):5291. PubMed ID: 32210315
[TBL] [Abstract][Full Text] [Related]
8. Rapid and robust transgenic high-grade glioma mouse models for therapy intervention studies.
de Vries NA; Bruggeman SW; Hulsman D; de Vries HI; Zevenhoven J; Buckle T; Hamans BC; Leenders WP; Beijnen JH; van Lohuizen M; Berns AJ; van Tellingen O
Clin Cancer Res; 2010 Jul; 16(13):3431-41. PubMed ID: 20472681
[TBL] [Abstract][Full Text] [Related]
9. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
10. Generation of cancerous neural stem cells forming glial tumor by oncogenic stimulation.
Lee JS; Lee HJ; Moon BH; Song SH; Lee MO; Shim SH; Kim HS; Lee MC; Kwon JT; Fornace AJ; Kim SU; Cha HJ
Stem Cell Rev Rep; 2012 Jun; 8(2):532-45. PubMed ID: 21755312
[TBL] [Abstract][Full Text] [Related]
11. [Influence of Nogo extracellular peptide residues 1-40 gene modification on survival and differentiation of neural stem cells after transplantation].
Wang L; Song Y; Yuan H; Liu L; Gong Q; Kong Q; Yang X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Nov; 27(11):1368-74. PubMed ID: 24501899
[TBL] [Abstract][Full Text] [Related]
12. Lentivirus-mediated microRNA-26a-modified neural stem cells improve brain injury in rats with cerebral palsy.
Guo Q; Zhang J; Zheng Z; Li X; Wang F; Liu S
J Cell Physiol; 2020 Feb; 235(2):1274-1286. PubMed ID: 31264214
[TBL] [Abstract][Full Text] [Related]
13. Single doublecortin gene therapy significantly reduces glioma tumor volume.
Santra M; Zheng X; Roberts C; Santra S; Lu M; Panda S; Jiang F; Chopp M
J Neurosci Res; 2010 Feb; 88(2):304-14. PubMed ID: 19681167
[TBL] [Abstract][Full Text] [Related]
14. Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model.
Shah K; Hingtgen S; Kasmieh R; Figueiredo JL; Garcia-Garcia E; Martinez-Serrano A; Breakefield X; Weissleder R
J Neurosci; 2008 Apr; 28(17):4406-13. PubMed ID: 18434519
[TBL] [Abstract][Full Text] [Related]
15. Lentivirus vectors: difficulties and hopes before clinical trials.
Kafri T
Curr Opin Mol Ther; 2001 Aug; 3(4):316-26. PubMed ID: 11525555
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
[TBL] [Abstract][Full Text] [Related]
17. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
[TBL] [Abstract][Full Text] [Related]
18. Recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes suppresses the growth of glioma in vivo.
Feng S; Han S; Pan D; Liu M; Feng X; Dong T; Li W; Wei X
Tumour Biol; 2014 May; 35(5):4411-7. PubMed ID: 24408016
[TBL] [Abstract][Full Text] [Related]
19. Glioblastomatous transformation of ganglioglioma: case report with reference to molecular genetic and flow cytometric analysis.
Kim NR; Wang KC; Bang JS; Choe G; Park Y; Kim SK; Cho BK; Chi JG
Pathol Int; 2003 Dec; 53(12):874-82. PubMed ID: 14629754
[TBL] [Abstract][Full Text] [Related]
20. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
